Melt Pharmaceuticals

Brentwood, United States

Melt Pharmaceuticals focuses on developing novel approach to providing procedural sedation and analgesia for short-term medical procedures.

$24.0M raised

Apr 2024

Series B

Health Care Health Diagnostics Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Melt Pharmaceuticals

How much funding has Melt Pharmaceuticals raised?

Melt Pharmaceuticals has raised $24.0M in total funding. The most recent round was Series B. The last funding was announced in April 2024.

Where is Melt Pharmaceuticals headquartered?

Melt Pharmaceuticals is headquartered in Brentwood, United States.

What does Melt Pharmaceuticals do?

Melt Pharmaceuticals focuses on developing novel approach to providing procedural sedation and analgesia for short-term medical procedures.

What stage is Melt Pharmaceuticals at?

Melt Pharmaceuticals is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 2, 2024.

MLA

"Melt Pharmaceuticals — Funding & Investors." VCBacked, April 2, 2024, https://www.vcbacked.co/company/melt-pharmaceuticals. Accessed July 3, 2026.

APA

VCBacked. (2024). Melt Pharmaceuticals — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/melt-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Melt Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/melt-pharmaceuticals |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 2, 2024.

Similar Companies in Health Care

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Circl Brain Health Metrics

Victoria$354K

YLAH

Bern$589K